Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
Henning GallJean-Luc VachiéryNobuhiro TanabeMichael HalankMauricio Orozco-LeviLisa MielniczukMiKyung ChangKai VogtländerEkkehard GrünigPublished in: Lung (2018)
Switching to riociguat from another PH-targeted therapy may be feasible in real-world clinical practice in the context of the current recommendations.
Keyphrases